Lv1
18 积分 2025-04-09 加入
Migraine
8天前
已完结
Migraine
8天前
已完结
Migraine
13天前
已完结
Leveraging a QSP Platform for Prediction of Clinical Efficacy and Safety Biomarkers in Immuno‐Oncology Combination Therapy
16天前
已完结
Camrelizumab plus CAPOX with camrelizumab based maintenance versus CAPOX alone as initial treatment for gastric or gastro-oesophageal junction adenocarcinoma: randomised phase 3 trial
2个月前
已完结
Understanding the therapeutic toolkit for inflammatory bowel disease
3个月前
已完结
Tiragolumab Plus Atezolizumab and Chemotherapy for Advanced Nonsquamous Non–Small Cell Lung Cancer
3个月前
已完结
Cancer burden and control in China: landscape, trends and challenges
3个月前
已完结
[China lymphoma diagnosis and treatment guideline (2026 edition)]
5个月前
已完结
Overall Survival With First-Line vs Second-Line CDK4/6 Inhibitor Use in Advanced Breast Cancer
5个月前
已完结
皖公网安备34019202002308
